<DOC>
	<DOCNO>NCT00063453</DOCNO>
	<brief_summary>To test whether supplementation selenium and/or vitamin E affect pulmonary function .</brief_summary>
	<brief_title>Supplemental Selenium Vitamin E Pulmonary Function</brief_title>
	<detailed_description>BACKGROUND : There compel evidence observational epidemiologic study intakes nutrient antioxidant property associate reduced risk chronic obstructive disease ( COPD ) increase lung function . This study ancillary multisite Selenium Vitamin E Cancer Prevention Trial ( SELECT ) , 4-arm placebo-controlled , double-blinded randomize trial 35,000 men test whether daily supplementation vitamin E ( 400mg alpha-tocopherol ) , selenium ( 200 microgram selenomethionine ) vitamin E selenium prevent prostate cancer . DESIGN NARRATIVE : This study ancillary multisite Selenium Vitamin E Cancer Prevention Trial ( SELECT ) , 4-arm placebo-controlled , double-blinded randomize trial 35,000 men test whether daily supplementation vitamin E ( 400mg alpha-tocopherol ) , selenium ( 200 microgram selenomethionine ) vitamin E selenium prevent prostate cancer . A total 3,000 SELECT participant enrol respiratory ancillary study , data collection extend include pulmonary function , respiratory disease , respiratory symptom . Biological measure nutrient exposure ( serum vitamin E selenium ) plasma lipid ( total high-density lipoprotein cholesterol ) collect participant oxidant burden ( urinary F2-isoprostane ) sub sample heavy smoker men COPD . The primary outcome change 36 month force expiratory volume first second ( FEV1 ) . FEV1 valid reliable measure respiratory function strongly predict COPD mortality . Extensive data diet dietary supplement use collect SELECT parent study . All specific aim examine pre-specified contrast 4 arm SELECT randomize trial . The underlying hypothesis supplement reduce age related decline FEV1 thus 3-year follow-up FEV1 , test longitudinal cross-sectional model . A secondary aim considers whether effect supplementation great among smoker ( high burden exogenous oxidant ) , purposive selection study site , comprise 25 % sample .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<criteria>Eligibility criterion : age ≥ 55 ( ≥ 50 AfricanAmericans ) serum prostatespecific antigen ≤ 4ng/mL clinical evidence prostate cancer Exclusion criterion : Off SELECT supplement</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>